SOD2 and Alzheimer disease: In line with these findings, work from our lab recently demonstrated that genetically reducing mitochondrial superoxide by SOD2 overexpression in the Tg2576 mouse model of AD shifts the Aβ pool towards a less amyloidogenic composition and therefore plaque deposition is reduced [27].